FUJIFILM Irvine Scientific to Sell Medical Media Business Unit to Astorg

  • FUJIFILM Irvine Scientific has announced the sale of its Medical Media Business Unit (MBU) to Astorg, a private equity firm.
  • The transaction, set to close on 1 April 2025, aligns with FUJIFILM’s strategic focus on life sciences and Astorg’s expansion in the assisted reproductive technology (ART) sector.

FUJIFILM Irvine Scientific, a global provider of cell culture solutions, has entered into an agreement to sell its Medical Media Business Unit (MBU) to Astorg, a private equity firm specialising in healthcare investments. The sale, expected to be completed by 1 April 2025, is part of FUJIFILM’s strategy to enhance its focus on life sciences and accelerate market growth.

The MBU, which operates within FUJIFILM’s Life Sciences Business Division, includes products for in vitro fertilisation (IVF), infertility research, and cytogenetic analysis. This unit will join Astorg’s growing MedTech portfolio, which recently expanded through the acquisition of Cook Medical’s Reproductive Health business and the take-private of Hamilton Thorne.

“After careful consideration, we made a strategic decision to sell the MBU because we recognised the different trajectories and needs of our businesses,” said Tim Mullane, President of FUJIFILM Irvine Scientific. He added that Astorg’s dedication to the IVF sector ensures the MBU will thrive under its ownership.

Astorg and FUJIFILM Irvine Scientific are collaborating on an integration plan to ensure continuity for medical media customers and partners. The transition is expected to be fully completed by January 2026, with FUJIFILM reaffirming its commitment to advancing its life sciences business.

Experience the future of contract manufacturing

Join us at CDMO Live, 7-8 May 2025 in Rotterdam for an exclusive live event dedicated to contract manufacturing partnerships. Apply for your ticket.

Sign up to our free weekly newsletter for all the latest contract manufacturing news.  Register here

Who do you rate?
Recommend a Supplier

Help us find the most innovative and trusted suppliers in Pharma and Biotech.